Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN)
CUSIP: 92790C104
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.01 par value per share
- Shares outstanding
- 102,220,000
- Total 13F shares
- 91,041,740
- Share change
- +3,738,994
- Total reported value
- $1,745,285,274
- Put/Call ratio
- 192%
- Price per share
- $19.17
- Number of holders
- 177
- Value change
- +$57,671,232
- Number of buys
- 107
- Number of sells
- 64
Quarterly Holders Quick Answers
What is CUSIP 92790C104?
CUSIP 92790C104 identifies VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92790C104:
Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
11,183,478
|
$254,424,126 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4.7%
|
4,804,006
|
$109,291,137 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.3%
|
4,420,097
|
$100,557,207 | — | 30 Sep 2024 | |
| VR Adviser, LLC |
13F
|
Company |
3.8%
|
3,882,709
|
$88,331,630 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.7%
|
3,750,945
|
$85,333,999 | — | 30 Sep 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3.4%
|
3,445,813
|
$78,392,246 | — | 30 Sep 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.8%
|
2,895,689
|
$65,876,925 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.8%
|
2,812,665
|
$63,988,129 | — | 30 Sep 2024 | |
| Commodore Capital LP |
13F
|
Company |
2.5%
|
2,550,124
|
$58,015,321 | — | 30 Sep 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.5%
|
2,511,295
|
$57,131,961 | — | 30 Sep 2024 | |
| Novo Holdings A/S |
13F
|
Company |
2.3%
|
2,385,000
|
$54,258,750 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
2,379,774
|
$54,139,859 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
2,242,925
|
$51,026,544 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.2%
|
2,202,739
|
$50,112,312 | — | 30 Sep 2024 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
4.5%
|
3,575,309
|
$48,373,931 | $0 | 31 Dec 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
2%
|
1,997,153
|
$45,435,231 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
1,991,490
|
$45,306,398 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.9%
|
1,958,847
|
$44,563,769 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,678,207
|
$38,179,209 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,493,311
|
$33,979,190 | — | 30 Sep 2024 | |
| Frazier Life Sciences Public Fund, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,505,200
|
$31,609,200 | — | 23 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
1,205,000
|
$27,413,750 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1%
|
1,025,337
|
$23,326,417 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.99%
|
1,009,879
|
$22,974,749 | — | 30 Sep 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.85%
|
870,000
|
$19,792,500 | — | 30 Sep 2024 | |
| Yiheng Capital Management, L.P. |
13F
|
Company |
0.83%
|
847,891
|
$19,289,520 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.8%
|
818,995
|
$18,632,136 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.75%
|
763,118
|
$17,360,934 | — | 30 Sep 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.73%
|
750,000
|
$17,062,500 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.73%
|
749,804
|
$17,057,277 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.72%
|
739,253
|
$16,818,006 | — | 30 Sep 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.72%
|
736,595
|
$16,757,536 | — | 30 Sep 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.68%
|
691,232
|
$15,725,528 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.67%
|
684,799
|
$15,579,179 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.65%
|
668,036
|
$15,197,819 | — | 30 Sep 2024 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.62%
|
633,090
|
$14,402,797 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
581,608
|
$13,231,583 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.55%
|
560,007
|
$12,740,159 | — | 30 Sep 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.51%
|
525,000
|
$11,943,750 | — | 30 Sep 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.51%
|
518,677
|
$11,799,902 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
516,213
|
$11,743,846 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.49%
|
499,977
|
$11,374,478 | — | 30 Sep 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.48%
|
494,924
|
$11,259,521 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.47%
|
482,136
|
$10,968,594 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.44%
|
444,800
|
$10,119,200 | — | 30 Sep 2024 | |
| Jonathan Violin |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
720,110
mixed-class rows
|
$10,099,005 | — | 02 Feb 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.43%
|
442,334
|
$10,063,111 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.42%
|
425,000
|
$9,668,750 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.39%
|
400,351
|
$9,107,986 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.38%
|
391,958
|
$8,917,000 | — | 30 Sep 2024 |
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) as of Q4 2024
As of 31 Dec 2024,
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,041,740 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Deep Track Capital, LP, VR Adviser, LLC, STATE STREET CORP, Fairmount Funds Management LLC, Kynam Capital Management, LP, TANG CAPITAL MANAGEMENT LLC, and COMMODORE CAPITAL LP.
This page lists
177
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
163
Q4 2024 holders
177
Holder diff
14
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.